BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Ian Wright and Gus Salem Join SISCAPA Leadership Team


1/2/2013 10:00:56 AM

WASHINGTON, DC – January 1, 2013 – SISCAPA Assay Technologies, Inc. (SAT), developer of precision mass spectrometry assays for clinical protein biomarkers, announces two important additions to its leadership team.

Ian Wright joins SAT as a consultant and primary architect of diagnostic business strategy. Previously Ian led a series of key activities at Siemens Healthcare Diagnostics, where he served as head of the Strategic Innovation group, head of Global Assay Development, (leading multi-site groups developing FDA-cleared assays on multiple platforms) and as Core Team Leader for development of the Vista® instrument platform (a program combining routine chemistry, LOCI® homogeneous immunoassay technology, ion-selective electrodes and nephelometry into a broad menu, next-generation, clinical analyzer).

Gustavo “Gus” Salem joins SAT’s Board of Directors, bringing over 20 years of life science sales, marketing, and business management experience. Most recently Gus was Vice-President and General Manager, LC/MS at Agilent Technologies, with responsibility for P&L, product development, and marketing strategy for Agilent’s mass spectrometry business. His previous positions included President and CEO of Assay Designs, a venture-backed life science company developing immunoassays and antibodies for drug discovery research and Division Manager of the Protein Separations Division at Bio-Rad Laboratories, where he managed the P&L, was responsible for the chromatography and electrophoresis product lines and headed the company’s Expression Proteomics program.

“SAT is extremely happy to welcome Ian and Gus to the SISCAPA team”, said Leigh Anderson, SAT’s CEO. “Their collective experience in global diagnostics and mass spectrometry businesses, including both the instrument and reagent components of the diagnostics industry, will help us accelerate the shift from conventional immunoassays to SAT’s high-specificity, multiplexable mass spectrometry-based assay products and services.”

About SISCAPA Assay Technologies, Inc.

SISCAPA Assay Technologies Inc. (SAT) delivers high-sensitivity, high-throughput specific assays for clinical protein biomarkers using SISCAPA® affinity-MS technology. Additional information about SISCAPA technology, reagents and business opportunities is available at www.SISCAPA.com

For more information contact Leigh Anderson at (301) 728-1451



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->